Last year's Allied prospectus also included an
agreement to aquire Medevco on top of the $4.4m capital raising for coridon and working capital.
860513 allied shares to be issued for Medevco
plus 860513 milestone deferred consideration shares.
Any more news on this aquisition.
alliedmedical offer information statement non-renounceable
rights issue